Early-phase clinical drug development of novel agents: a changing paradigm

Ann Oncol. 2019 Jul 1;30(7):1033-1037. doi: 10.1093/annonc/mdz165.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Azetidines
  • Drug Development
  • Humans
  • Neoplasms*
  • Piperidines

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Azetidines
  • Piperidines
  • atezolizumab
  • cobimetinib